| Adam Joseph Wood, OD | |
|
7580 Cox Ln, West Chester, OH 45069-6519 | |
| (513) 759-5100 | |
| (513) 759-5801 |
| Full Name | Adam Joseph Wood |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 12 Years |
| Location | 7580 Cox Ln, West Chester, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558626788 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 6170 (Ohio) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Customeyes Vision Center Inc | 8123250040 | 3 |
News Archive
A long-term study has found a significant connection between sleep problems in children's toddler years and the chance that they'll use alcohol, cigarettes, and drugs early in their teen years. Young teens whose preschool sleep habits were poor were more than twice as likely to use drugs, tobacco, or alcohol.
GTCR, one of the country's leading private equity firms, announced today that Actient Pharmaceuticals, LLC has successfully completed a transaction to license and acquire six pharmaceutical products from UCB, Inc., a subsidiary of UCB SA, an international biopharmaceutical company based in Brussels, Belgium.
Researchers at Yale School of Medicine are able to detect deficits in social attention in infants as young as six months of age who later develop Autism Spectrum Disorders (ASD).
CoLucid Pharmaceuticals, Inc., a privately held biopharmaceutical company, has reached agreement with the Food and Drug Administration's Division of Neurology Products concerning the development strategy for lasmiditan at a recently completed End of Phase 2 meeting.
› Verified 7 days ago
| Provider Name | Customeyes Vision Center Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1962825802 PECOS PAC ID: 8123250040 Enrollment ID: O20140408001342 |
News Archive
A long-term study has found a significant connection between sleep problems in children's toddler years and the chance that they'll use alcohol, cigarettes, and drugs early in their teen years. Young teens whose preschool sleep habits were poor were more than twice as likely to use drugs, tobacco, or alcohol.
GTCR, one of the country's leading private equity firms, announced today that Actient Pharmaceuticals, LLC has successfully completed a transaction to license and acquire six pharmaceutical products from UCB, Inc., a subsidiary of UCB SA, an international biopharmaceutical company based in Brussels, Belgium.
Researchers at Yale School of Medicine are able to detect deficits in social attention in infants as young as six months of age who later develop Autism Spectrum Disorders (ASD).
CoLucid Pharmaceuticals, Inc., a privately held biopharmaceutical company, has reached agreement with the Food and Drug Administration's Division of Neurology Products concerning the development strategy for lasmiditan at a recently completed End of Phase 2 meeting.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Adam Joseph Wood, OD 7580 Cox Ln, West Chester, OH 45069-6519 Ph: (513) 759-5100 | Adam Joseph Wood, OD 7580 Cox Ln, West Chester, OH 45069-6519 Ph: (513) 759-5100 |
News Archive
A long-term study has found a significant connection between sleep problems in children's toddler years and the chance that they'll use alcohol, cigarettes, and drugs early in their teen years. Young teens whose preschool sleep habits were poor were more than twice as likely to use drugs, tobacco, or alcohol.
GTCR, one of the country's leading private equity firms, announced today that Actient Pharmaceuticals, LLC has successfully completed a transaction to license and acquire six pharmaceutical products from UCB, Inc., a subsidiary of UCB SA, an international biopharmaceutical company based in Brussels, Belgium.
Researchers at Yale School of Medicine are able to detect deficits in social attention in infants as young as six months of age who later develop Autism Spectrum Disorders (ASD).
CoLucid Pharmaceuticals, Inc., a privately held biopharmaceutical company, has reached agreement with the Food and Drug Administration's Division of Neurology Products concerning the development strategy for lasmiditan at a recently completed End of Phase 2 meeting.
› Verified 7 days ago
Cincinnati Eyecare Team Optometrist Medicare: Not Enrolled in Medicare Practice Location: 8629 N Pavillion, West Chester, OH 45069 Phone: 636-200-4393 Fax: 513-942-5321 | |
Dr. Diana Watkins Gilbert, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 8629 N Pavillion, West Chester, OH 45069 Phone: 513-860-0400 | |
Dawn M. Moczek, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 7675 Voice Of America Centre Drive, West Chester, OH 45069 Phone: 513-777-4857 | |
Dr. Jason Kennan Winterbottom, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 7849 Tylersville Rd, West Chester, OH 45069 Phone: 513-298-5170 Fax: 513-755-0658 | |
Mr. Lawrence G Schneider, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 6834 Tylersville Rd, West Chester, OH 45069 Phone: 513-779-3933 Fax: 513-779-6760 | |
Deborah Radeline Bereda, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 8179 Princeton Glendale Rd, Suite E, West Chester, OH 45069 Phone: 513-860-5525 Fax: 513-860-3313 | |
Dr. Kenneth Crawford O.d. Inc., O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 7793 Joan Dr, West Chester, OH 45069 Phone: 513-755-7775 Fax: 513-755-7773 |